Kipnis Danielle, Lin Michele, Pacheco Alissa, Mensah Nia, Gu Yu, Macpherson Chelsea E, Kempner Kelsey, Parker Anita, Coley R Bernard, Coley Denise, Shah Hiral, Quinn Lori
Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, USA.
Long Island University, Brooklyn, NY, USA.
J Racial Ethn Health Disparities. 2025 Jun;12(3):1811-1823. doi: 10.1007/s40615-024-02011-2. Epub 2024 May 8.
Parkinson disease (PD) is the second most common neurodegenerative disease. Members of the Black Diaspora (MBD) and Hispanic/Latinx people are less likely to receive a timely diagnosis following the onset of symptoms and more likely to experience greater disease severity due to late diagnosis. Historically marginalized populations (i.e., MBD, Hispanic, and Latinx communities) are not accurately represented in research; this, along with many other barriers, compounds underreporting and lack of recognition of PD. It is important to understand barriers to early diagnosis and healthcare access for these historically marginalized populations from the community's perspective.
Our team conducted two focus groups to identify barriers and facilitators to PD healthcare-seeking behavior. We sought to identify which barriers are modifiable to ultimately improve engagement in neurological care for MBD and Hispanic individuals affected by PD.
We enrolled 15 participants (13 female; African/African American/Black n = 10, Hispanic/Puerto Rican n = 3, other n = 2) for two focus groups. Discussions revealed sources of barriers to healthcare-seeking behavior in three main domains: legacy of racism in the United States, ancestral cultural environment, and healthcare system access. These sources influenced individuals' PD knowledge and familiarity. Additionally, participants expressed a desire to know more about PD and called for increased community-based programming for education and awareness.
This paper uses a community-based participatory research approach to describe the experiences of MBD, Hispanic, and Latinx people in Manhattan and the surrounding areas in relation to possible sources of healthcare disparities and delayed PD diagnosis. These sources have broad implications and should be addressed through collaborative community programming.
帕金森病(PD)是第二常见的神经退行性疾病。非洲裔散居群体成员(MBD)以及西班牙裔/拉丁裔人群在出现症状后不太可能及时得到诊断,并且由于诊断延迟,更有可能经历更严重的疾病。历史上被边缘化的群体(即MBD、西班牙裔和拉丁裔社区)在研究中没有得到准确体现;这与许多其他障碍一起,加剧了帕金森病报告不足和未被认识的情况。从社区角度了解这些历史上被边缘化群体早期诊断和获得医疗服务的障碍非常重要。
我们的团队进行了两个焦点小组讨论,以确定帕金森病就医行为的障碍和促进因素。我们试图确定哪些障碍是可以改变的,以最终提高受帕金森病影响的MBD和西班牙裔个体对神经科护理的参与度。
我们为两个焦点小组招募了15名参与者(13名女性;非洲/非裔美国人/黑人n = 10,西班牙裔/波多黎各人n = 3,其他n = 2)。讨论揭示了就医行为障碍的三个主要领域的来源:美国的种族主义遗留问题、祖传文化环境和医疗系统可及性。这些来源影响了个体对帕金森病的了解和熟悉程度。此外,参与者表示希望更多地了解帕金森病,并呼吁增加基于社区的教育和宣传项目。
本文采用基于社区的参与性研究方法,描述了曼哈顿及周边地区MBD、西班牙裔和拉丁裔人群在医疗保健差距和帕金森病诊断延迟可能来源方面的经历。这些来源具有广泛影响,应通过合作的社区项目加以解决。